MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal Study

Why did Tesla shares drop amid Musk-Trump feud? How will Trump’s megabill affect Medicaid funding? What caused Jeff Bezos to sell $737 million shares? Why did Senate remove AI regulation ban from bill? How are Trump’s tariffs delaying Fed rate cuts? What impact will Home Depot’s $4.3B acquisition have? Why is Lululemon suing Costco over dupes?

MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal Study

benzinga.com/news/health-care/25/06/46165348/exclusive-mira-pharmaceuticals-soon-to-be-acquired-weight-loss-drug-reverses-obesity-markers-and

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Monday revealed new animal study results from SKNY-1, a next-generation oral therapeutic.
The company says the findings further support the advancement of SKNY-1 toward Investigational New Drug (IND) enabling studies.
With obesity and smoking…

This story appeared on benzinga.com, 2025-06-30 11:20:42.